Shapiro S - Search Results

1

Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response to interferon-beta therapy in relapsing and secondary-progressive multiple sclerosis patients.

Galboiz Y, Shapiro S, Lahat N, Rawashdeh H, Miller A. Galboiz Y, et al. Among authors: shapiro s. Ann Neurol. 2001 Oct;50(4):443-51. doi: 10.1002/ana.1218. Ann Neurol. 2001. PMID: 11601495

2

Regulation of endothelial matrix metalloproteinase-2 by hypoxia/reoxygenation.

Ben-Yosef Y, Lahat N, Shapiro S, Bitterman H, Miller A. Ben-Yosef Y, et al. Among authors: shapiro s. Circ Res. 2002 Apr 19;90(7):784-91. doi: 10.1161/01.res.0000015588.70132.dc. Circ Res. 2002. PMID: 11964371

3

The role of IL-18 and IL-12 in the modulation of matrix metalloproteinases and their tissue inhibitors in monocytic cells.

Abraham M, Shapiro S, Lahat N, Miller A. Abraham M, et al. Among authors: shapiro s. Int Immunol. 2002 Dec;14(12):1449-57. doi: 10.1093/intimm/dxf108. Int Immunol. 2002. PMID: 12456593

4

Modulation of monocytes matrix metalloproteinase-2, MT1-MMP and TIMP-2 by interferon-gamma and -beta: implications to multiple sclerosis.

Galboiz Y, Shapiro S, Lahat N, Miller A. Galboiz Y, et al. Among authors: shapiro s. J Neuroimmunol. 2002 Oct;131(1-2):191-200. doi: 10.1016/s0165-5728(02)00266-7. J Neuroimmunol. 2002. PMID: 12458052

5

The 'immunological-synapse' at its APC side in relapsing and secondary-progressive multiple sclerosis: modulation by interferon-beta.

Shapiro S, Galboiz Y, Lahat N, Kinarty A, Miller A. Shapiro S, et al. J Neuroimmunol. 2003 Nov;144(1-2):116-24. doi: 10.1016/j.jneuroim.2003.08.002. J Neuroimmunol. 2003. PMID: 14597105 Clinical Trial.

6

Immunoregulatory effects of interferon-beta and interacting cytokines on human vascular endothelial cells. Implications for multiple sclerosis autoimmune diseases.

Miller A, Lanir N, Shapiro S, Revel M, Honigman S, Kinarty A, Lahat N. Miller A, et al. Among authors: shapiro s. J Neuroimmunol. 1996 Feb;64(2):151-61. doi: 10.1016/0165-5728(95)00164-6. J Neuroimmunol. 1996. PMID: 8632057

7

Intravenous gamma globulin inhibits the production of matrix metalloproteinase-9 in macrophages.

Shapiro S, Shoenfeld Y, Gilburd B, Sobel E, Lahat N. Shapiro S, et al. Cancer. 2002 Nov 1;95(9):2032-7. doi: 10.1002/cncr.10905. Cancer. 2002. PMID: 12404299 Free article.

8

Inorganic lead enhances cytokine-induced elevation of matrix metalloproteinase MMP-9 expression in glial cells.

Lahat N, Shapiro S, Froom P, Kristal-Boneh E, Inspector M, Miller A. Lahat N, et al. Among authors: shapiro s. J Neuroimmunol. 2002 Nov;132(1-2):123-8. doi: 10.1016/s0165-5728(02)00323-5. J Neuroimmunol. 2002. PMID: 12417442

9

Expression of matrix metalloproteinases, sICAM-1 and IL-8 in CSF from children with meningitis.

Shapiro S, Miller A, Lahat N, Sobel E, Lerner A. Shapiro S, et al. J Neurol Sci. 2003 Jan 15;206(1):43-8. doi: 10.1016/s0022-510x(02)00317-9. J Neurol Sci. 2003. PMID: 12480084

10

Expression of matrix metalloproteinases in articular cartilage of temporomandibular and knee joints of mice during growth, maturation, and aging.

Gepstein A, Shapiro S, Arbel G, Lahat N, Livne E. Gepstein A, et al. Among authors: shapiro s. Arthritis Rheum. 2002 Dec;46(12):3240-50. doi: 10.1002/art.10690. Arthritis Rheum. 2002. PMID: 12483728 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,932 results

Search Page

Filters